PAST FSASP CONGRESSES:
Laboratory Medicine Congress 2011
Visit www.labmedicine2011.co.za for further information.
Dr Alan Remaley
Alan T. Remaley, M.D., Ph.D., is a medical officer in the Public Health Service at the National Institutes of Health. Dr. Remaley received his B.S. in Biochemistry and Chemistry from the University of Pittsburgh in 1981. He received in 1987 a M.D. and Ph.D. (Biochemistry) degree from the University of Pittsburgh. He completed in 1990 a residency in Clinical Pathology at the University of Pennsylvania and became board certified in Clinical Pathology in 1992. He joined the National Institutes of Health in 1990, as a medical staff fellow, and did a postdoctoral fellowship on lipoprotein metabolism at the Molecular Disease Branch of the National Heart, Lung, and Blood Institute. He became in 1995 a senior staff member of the Department of Laboratory Medicine at the National Institutes of Health, where he directs the Immunoassay and HPLC/Mass Spectrometry laboratories. As of 2005, he became the section chief of the Lipoprotein Metabolism Laboratory at NHLBI. His current research is focused on the mechanism of action of the ABCA1 transporter and its role in HDL metabolism. In addition, he is involved in developing new diagnostic immunoassays and lipoprotein assays. He is the author of over 150 publications, mostly in the fields of lipoprotein metabolism and clinical pathology, and has four patents. He is a member of the editorial board for Clinical Chemistry, Open Atherosclerosis, and Journal of Pediatric Clinical Biochemistry. He is a current member of the FDA Advisory Board for Clinical Chemistry/Clinical Toxicology Devices and a member of the CAP Proficiency Test Committee for Special Chemistry. He is a past chair of the Capital Section of the American Association of Clinical Chemistry and the Lipoprotein and Vascular Disease Division of the American Association of Clinical Chemistry.
Professor James Leonard
Professor James Leonard is now retired. He qualified in the University of Cambridge and St Thomas’s Hospital in London. After paediatric training, he held senior appointments at The Hospital for Sick Children, Great Ormond Street, London and the Institute of Child Health in the University of London, becoming Professor of Paediatric Metabolic Disease in 1992. He has a special interest in disorders of intermediary metabolism and has published more than 300 papers, reviews and chapters. He has lectured widely throughout the world.
Janice Gill is the Program Manager of the RCPA Chemical Pathology Quality Assurance Programs Group based in Adelaide, Australia. The RCPA Chemical Pathology Quality Assurance Programs provides over 30 different external quality assurance (EQA) programs to pathology laboratories worldwide as well as specifically designed PoCT EQA programs. In this position Janice is responsible for the development and overall management of all the biochemistry external quality assurance programs and the day-to-day running of the QAP Office. Since Janice joined the QAP in 1994 she has held the positions of Scientific Officer, Managing Scientist and Program Manager.
Prior to this Janice worked for over 20 years as a Biochemist in pathology laboratories. Janice is the Co-Chair of the International Federation of Clinical Chemistry Committee on Analytical Quality and is a member of the Australasian Association Clinical Biochemists PoCT Working Party.
Juan Miguel Venturello
Industrial Engineer followed with a specialization in Project Management. Worked for 4 years in Roche Diagnostics as Project Leader responsible for development and launch of cobas IT 1000, a leading POC IT system. After, managed Asepeyo’s (Spain largest private healthcare provider) IT integration business, and contributed to the development of HL7 Spain and Latin America, a hospital IT connectivity standard: taught courses, certified engineers and spoke at industry events on connectivity and IT integration. Further education through a Full Time Master in Business Administration (MBA) at IESE Business School. Global Marketing Manager responsible for Roche Diagnostic’s line of POC IT products. For the last 2 years, Managing Director in EMEA for Laboratory Data Systems, a company entirely dedicated to providing state of the art POC connectivity solutions. Member of AACC, IEEE and HL7.
Mrs. Naik works at the National Institute for Occupational Health (NIOH) in Johannesburg, South Africa and is the head of the Analytical Services for the past 14 years. She has a Masters degree in Physiology, Diploma in Occupational Health and Diplomas in Medical Technology in the category chemical pathology, microbiology and haematology.
She is actively involved in developing analytical capacity in environmental and biological monitoring in occupational and environmental health in South Africa to service academic institutes and public as well as private sectors of the industries. This is achieved through establishing internationally recognized, ISO Code 15189 and 17025 accredited laboratories providing analyses in toxic substances namely metals organic compounds including pesticides monitoring.
She is also involved in developing capacity in occupational health and chemical exposures in occupational and environmental health with special emphasis on biological and environmental monitoring capacity within South Africa, India and in Tanzania. This is achieved through organizing education programmes in biological monitoring by conducting courses, seminars, workshops and laboratory training programmes.
On behalf of the Organizing Committees, it is our great pleasure to invite you to participate in the 2010 Federation of South African Pathology Societies annual congress. The 2010 meeting will be held at the Lord Charles Hotel in Somerset West, Cape Town, South Africa, from 2-5 September 2010.
Visit www.pathvine2010.co.za for further information.
The first combined congress of the Society of Medical Laboratory Technologists of South Africa, the Federation of South African Societies of Pathology and the South African Society of Clinical Cytology was held at the ICC, Durban, 6 - 10 September 2009
Visit www.pathtechcongress.co.za for further information.
|Guest: Prof Gert Utermann
||Medical University of Innsbruck, Austria
a. Genetic variation and risk for coronary heart disease.
b. The Smith-Lemli-Opitz Syndrome metabolic malformatin disorder.
Path Update 48
The 48th Annual Congress of the Federation of South African Societies of Pathology (FSASP)
was held at the Cape Sun Hotel, Cape Town, 19 - 21 July 2008
Visit www.pathupdate48.org.za for further information.
|Guest: Professor Dennis Lo
||Chinese University of Hong Kong
a. Plasma nucleic acids as a new platform for molecular diagnosis
b. Epigenetics: a new source of markers for molecular diagnosis
The 47th Annual Congress of the Federation of South African Societies of Pathology (FSASP) was held at Aventura (Bela-Bela /Warmbaths) 20 – 22 July 2007.
|Guest: Prof David Sacks
a. Diabetes mellitus 2007:The role of the Laboratory
b. Hemoglobin Alc in the management of patients with diabetes: from chaos to harmony
ABC of Quality Control- A Problem Based Approach
Step by Step Approach to Evaluation and Comparison of Analytical Methods
J. M. Kuyl